Table 2.
Bhutan | Vietnam | Myanmar | ||||
---|---|---|---|---|---|---|
n | 200 | 102 | 69 | |||
Mean age | 36.6 ± 13.8* † | 44.5 ± 13.0 | 40.1 ± 11.5** | |||
Male | 94 | (47.0%) | 47 | (46.1%) | 28 | (40.6%) |
Gastric cancer | 1 | (0.5%) | 0 | (0.0%) | 1 | (1.4%) |
Peptic ulcer | 38 | (19.0%) | 26 | (25.5%) | 2 | (2.9%) |
Gastritis | 161 | (80.5%) | 76 | (74.5%) | 66 | (95.7%) |
cagA | 200 | (100.0%)* † | 97 | (95.1%) | 61 | (88.4%)** |
vacA s1 | 200 | (100.0%) | 102 | (100.0%) | 67 | (97.1%) |
vacA m1 | 154 | (77.0%)* † | 48 | (47.1%) | 61 | (88.4%)** |
jhp0562-positive | 197 | (98.5%) | 99 | (97.1%) | 67 | (97.1%) |
β-(1,3)galT-positive | 34 | (17.0%)† | 18 | (17.6%) | 50 | (72.5%)** |
jhp0562-positive/β-(1,3)galT-negative | 166 | (83.0%)† | 84 | (82.4%) | 19 | (27.5%)** |
jhp0562-negative/β-(1,3)galT-positive | 3 | (1.5%) | 3 | (2.9%) | 2 | (2.9%) |
Double-positive of jhp0562 and β-(1,3)galT | 31 | (15.5%)† | 15 | (14.7%) | 48 | (69.6%)** |
cagA/vacA s1m1 | 154 | (77.0%)* | 46 | (45.1%) | 55 | (79.7%)** |
cagA/vacA s1m1/jhp0562-positive/β-(1,3)galT-negative | 128 | (64.0%)* † | 37 | (36.3%) | 15 | (21.7%)** |
∗ indicates a statistically significant difference between Bhutan and Vietnam.
∗∗ indicates a statistically significant difference between Myanmar and Vietnam.
† indicates a statistically significant difference between Bhutan and Myanmar.